Yan et al. recently reported MR1-deficient mice (which lack MAIT cells) showed improved anti-tumor immunity when assessed using models of experimental lung metastasis, subcutaneous tumor growth, and de novo carcinogenesis (102). This evidence concerns the gene MR1 and neoplasm.